About Technology Issues FAQ

Links

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.